Cytosolix develops novel oral and IV derivatives that target tumor acidity to improve the efficacy of small molecule cancer therapeutics. Cytosolix's Tumor Activated Permeability System, produces weakly-acidic derivatives of known oncology drugs, that enhance the uptake by cancer cells while restricting the uptake by healthy cells, enabling physicians to get safer and more effective therapy for drugs with dose-limiting toxicities.

Tolland, CT, USA

Cytosolix

BlueYard invests in founders with transforming ideas that decentralize markets, empower users and liberate data

BY Capital Management GmbH

BlueYard Capital

Tell us about your professional DNA to get discovered by any company in our network with opportunities relevant to your career goals.

Leverage our network to build your career.

#### Hello,
In 5 quick steps, tell us about the type of opportunities you'd be interested in next. We'll use this information to connect you to relevant opportunities in the BlueYard Capital network as they come up. You can always update this information later.

As our companies grow, they look to us to help them find the best talent.

Signal that you'd be interested in working with a BlueYard Capital company to help us put the right opportunities at great companies on your radar. The choice to pursue a new career move is then up to you.

Explore open positions at BlueYard portfolio companies

Is this your company?